Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  25,337 results for ""IMATINIB""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1.

  • Authors : Wu X; Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.; Iwatsuki M

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; F-Box-WD Repeat-Containing Protein 7*/F-Box-WD Repeat-Containing Protein 7*/F-Box-WD Repeat-Containing Protein 7*/metabolism ; Gastrointestinal Neoplasms*/Gastrointestinal Neoplasms*/Gastrointestinal Neoplasms*/drug therapy

  • Source: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Mar; Vol. 27 (2), pp. 235-247. Date Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Resolution of gastric antral vascular ectasia following cessation of imatinib.

  • Authors : Maye JA; Medicine, West Suffolk Hospital, Bury Saint Edmunds, UK .; Baker O

Subjects: Anemia, Iron-Deficiency*/Anemia, Iron-Deficiency*/Anemia, Iron-Deficiency*/drug therapy ; Anemia, Iron-Deficiency*/Anemia, Iron-Deficiency*/Anemia, Iron-Deficiency*/etiology ; Gastric Antral Vascular Ectasia*/Gastric Antral Vascular Ectasia*/Gastric Antral Vascular Ectasia*/chemically induced

  • Source: BMJ case reports [BMJ Case Rep] 2024 Feb 22; Vol. 17 (2). Date of Electronic Publication: 2024 Feb 22.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X

Record details

Read More Add to Saved list
×
Academic Journal

Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes.

  • Authors : Fu R; Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China.; Chang R

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/administration & dosage ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy ; Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/administration & dosage

  • Source: Pharmaceutical development and technology [Pharm Dev Technol] 2024 Jan; Vol. 29 (1), pp. 52-61. Date of Electronic Publication: 2024 Jan 30.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9610932 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Imatinib mesylate-induced acute hepatotoxicity.

  • Authors : Frikha I; Department of Hematology, Hedi Chaker Hospital, University of Sfax, Tunisia.; Fakhfakh Y

Subjects: Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/etiology ; Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/adverse effects ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy

  • Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Dec; Vol. 29 (8), pp. 2027-2030. Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study

  • Authors : Savaş EM; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Türkiye; Yılmaz S

Subjects: Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/drug therapy

  • Source: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Dec 05; Vol. 40 (4), pp. 236-241. Date of Electronic Publication: 2023 Publisher: Galenos Yayinevi Country of Publication: Turkey NLM ID: 9606065 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers.

  • Authors : Cantu-Rodriguez OG; Universidad Autonoma de Nuevo Leon, Facultad de Medicina y Hospital Universitario 'Dr. José Eleuterio González', Servicio de Hematologia, Monterrey, Nuevo León, Mexico. Electronic address: .; Osorno-Rodriguez KL

Subjects: Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/administration & dosage ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/mortality

  • Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Nov; Vol. 23 (11), pp. e386-e392. Date of Electronic Publication: 2023 Aug 08.Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach.

  • Authors : Kong SH; Department of Surgery, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine Cancer Research Institute, 101, Daehak-ro, Jongno-gu, Seoul, 0380, South Korea.; Kurokawa Y

Subjects: Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/drug therapy ; Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/surgery ; Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/Gastrointestinal Stromal Tumors*/pathology

  • Source: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2023 Sep; Vol. 26 (5), pp. 775-787. Date Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A biophysical framework for double-drugging kinases.

  • Authors : Kim C; Department of Biochemistry, Brandeis University, Waltham, MA 02454.; HHMI, Brandeis University, Waltham, MA 02454.

Subjects: Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/chemistry ; Imatinib Mesylate*/Imatinib Mesylate*/Imatinib Mesylate*/pharmacology ; Niacinamide*/Niacinamide*/Niacinamide*/chemistry

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Aug 22; Vol. 120 (34), pp. e2304611120. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.

  • Authors : Teranishi R; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Takahashi T

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/blood ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: International journal of clinical oncology [Int J Clin Oncol] 2023 May; Vol. 28 (5), pp. 680-687. Date of Electronic Publication: 2023 Mar 27.Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.

  • Authors : Lee CH; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, New Taipei City 23561, Taiwan.; Ph.D. Program in Medicine Biotechnology, College of Medical Science and Technology, Taipei Medical University, New Taipei City 23561, Taiwan.

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/pharmacology ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy

  • Source: Cells [Cells] 2024 Apr 02; Vol. 13 (7). Date of Electronic Publication: 2024 Apr 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read More Add to Saved list
×
  • 1-10 of  25,337 results for ""IMATINIB""